- Home
- NRC vs BNTC Comparison
NRC vs BNTC Comparison
Compare NRC & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRC
- BNTC
- Stock Information
- Founded
- NRC 1981
- BNTC 1995
- Country
- NRC United States
- BNTC United States
- Employees
- NRC N/A
- BNTC N/A
- Industry
- NRC Biotechnology: Commercial Physical & Biological Resarch
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- NRC Health Care
- BNTC Health Care
- Exchange
- NRC Nasdaq
- BNTC Nasdaq
- Market Cap
- NRC 394.2M
- BNTC 352.5M
- IPO Year
- NRC N/A
- BNTC N/A
- Fundamental
- Price
- NRC $14.04
- BNTC $13.60
- Analyst Decision
- NRC
- BNTC Strong Buy
- Analyst Count
- NRC 0
- BNTC 7
- Target Price
- NRC N/A
- BNTC $24.71
- AVG Volume (30 Days)
- NRC 101.8K
- BNTC 33.9K
- Earning Date
- NRC 04-28-2025
- BNTC 05-14-2025
- Dividend Yield
- NRC 3.44%
- BNTC N/A
- EPS Growth
- NRC N/A
- BNTC N/A
- EPS
- NRC 1.02
- BNTC N/A
- Revenue
- NRC $141,298,000.00
- BNTC N/A
- Revenue This Year
- NRC N/A
- BNTC N/A
- Revenue Next Year
- NRC N/A
- BNTC N/A
- P/E Ratio
- NRC $13.71
- BNTC N/A
- Revenue Growth
- NRC N/A
- BNTC N/A
- 52 Week Low
- NRC $9.76
- BNTC $5.74
- 52 Week High
- NRC $35.81
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- NRC 63.42
- BNTC 50.41
- Support Level
- NRC $13.28
- BNTC $12.30
- Resistance Level
- NRC $14.11
- BNTC $14.16
- Average True Range (ATR)
- NRC 0.71
- BNTC 1.00
- MACD
- NRC 0.28
- BNTC -0.07
- Stochastic Oscillator
- NRC 95.38
- BNTC 38.35
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.